Foamix Pharmaceuticals Ltd. Share-based Payment Arrangement, Expense
Foamix Pharmaceuticals Ltd. reported Share-based Payment Arrangement, Expense of $690.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, expense for fiscal 2018 was $690.00K, a 34.78% decline from fiscal 2017.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, expense for fiscal 2017 was $1.06M.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|
| 2018-12-31 | $690.00K 10-K · filed 2020-03-12 | $239.00K 10-K · filed 2019-02-28 | |
| 2018-11-19 | $47.00K 10-K · filed 2019-02-28 | ||
| 2017-12-31 | $1.06M 10-K · filed 2020-03-12 |